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Noakes misses the point
To the Editor: We are writing to point out inaccuracies in Professor 
Noakes’ critique of the Women’s Health Initiative (WHI) trial of 
dietary modification.[1] Difficult as it may be for proponents of low 
carbohydrate, high fat diets to accept, it is an inconvenient truth that 
the findings from the WHI trial negate their thesis that diets higher in 
carbohydrates and lower in fats lead to obesity and insulin resistance 
and increase diabetes risk. Instead, the lower fat diet rigorously tested 
in a large number of participants in the WHI led to less weight gain, 
improved insulin resistance (at 1 year), and no increase in diabetes 
risk compared with the control diet.[2-4] Diabetes risk appeared to 
be reduced proportionately to decreases in fat intake and weight. [4] 
These findings are in agreement with findings from the Diabetes 
Prevention Trial (of people with pre-diabetes treated with a low-fat, 
calorie-restricted diet plus exercise) that reduction in diabetes risk 
was proportional to reduction in fat intake and weight loss.[5]
Throughout his critique, Professor Noakes focuses on subgroup 
findings rather than the robust overall findings from the WHI 
randomised trial. Subgroup analyses are less reliable because they 
have insufficient power a priori due to small numbers, and because 
when multiple subgroups are tested, the chance of spurious findings 
increases. Nonetheless, we will address some of the subgroups he 
finds of interest. Contrary to his implications, those who started with 
the leanest body weight gained less weight on the diet than did the 
control group;[2] the subgroup with least insulin resistance was not at 
significantly greater risk of developing diabetes (and was comprised 
of a grand total of 19 cases);[4] and while the subgroup with diabetes 
at baseline (n=216) had greater elevations in glucose, this observation 
was inconsistent with findings in the subgroups with baseline 
impaired fasting glucose or insulin resistance.[3]  
As emphasised throughout the first report,[6] the WHI trial was 
not designed to test the diet-heart hypothesis. Rather, the trial was 
designed to test whether reducing total dietary fat would reduce the 
risk of cancer; a secondary aim was ‘to test whether such a dietary 
intervention, which did not focus on the intake of specific fats, 
would also reduce the risk of cardiovascular disease.’[6] Although the 
overall result showed no effect on coronary heart disease (CHD) 
risk, subgroup analyses found reduced risks in women who achieved 
the greatest reductions in saturated fat or trans fat intakes. [6] Small 
changes in low-density lipoprotein (LDL)-cholesterol measured in 
a random 4.3% sample were consistent with the overall null finding 
for CHD; while the larger decreases in LDL-cholesterol in women 
who achieved the greatest reductions in saturated and trans fat 
intakes also were consistent with the subgroup findings for CHD. [6] 
Taken together, these findings are consistent with the diet-heart 
hypothesis.
Professor Noakes makes much of the increased risk of CHD in 
the small (3.4%) sub-cohort with baseline disease.[6] This increased 
risk is likely to be a chance finding, because there is no biologic 
basis for expecting a different outcome in this subgroup, as shown in 
cholesterol-lowering trials of women with prior disease.[7] 
Finally, the cost of the WHI diet trial was not $700 million – that 
figure represents the cost of the entire multifaceted WHI programme, 
which included 161 808 women (48 835 in the diet trial) over a period 
of 14 years. The WHI diet trial and the overall WHI programme 
continue to generate extraordinarily valuable findings that inform 
women’s health. 
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